All In Biotech

Drugs by condition

Drugs approved for type 1 diabetes

Brand-name prescription drugs and biologics whose FDA label lists type 1 diabetes as an approved use. Matched on the label phrases: "type 1 diabetes".

Last checked: Nov 20, 2026Source: FDA labels (openFDA), Drugs@FDAMethods & limitations

Brand-name drugs approved

39

Still marketed, NDA or BLA

Drug classes

8

Novel drugs

16

New molecular entities and new biologics

In development

12

Investigational drugs in Phase 2 or 3

Newest approvals

The most recently first-approved brand-name drugs for type 1 diabetes.

  • Onswik (Insulin Efsitora Alfa-Gobe) · Eli Lilly and CO NovelSep 23, 2026
  • Zituvimet Xr (Metformin Hydrochloride, Sitagliptin) · Zydus Lifesciences Jul 18, 2024
  • Zituvimet (Metformin Hydrochloride, Sitagliptin) · Zydus Lifesciences Nov 3, 2023
  • Zituvio (Sitagliptin) · Zydus Lifesciences Oct 18, 2023
  • Brenzavvy (Bexagliflozin) · Theracosbio NovelJan 20, 2023

All approved drugs for type 1 diabetes, by class

Every marketed NDA or BLA whose current FDA label names this condition in its Indications and Usage section, plus 75 generic labels. A drug can be approved for only part of a condition (one subtype or stage, or as add-on therapy), so check its label.

Sodium-Glucose Cotransporter 2 Inhibitor (6)

  • Brenzavvy Bexagliflozin · Theracosbio · 2023
  • Jardiance Empagliflozin · Boehringer Ingelheim · 2014
  • Trijardy Xr Empagliflozin, Linagliptin, Metformin Hydrochloride · Boehringer Ingelheim · 2020
  • Synjardy Xr Empagliflozin, Metformin Hydrochloride · Boehringer Ingelheim · 2016
  • Synjardy Empagliflozin, Metformin Hydrochloride · Boehringer Ingelheim · 2015
  • Glyxambi Empagliflozin, Linagliptin · Boehringer Ingelheim · 2015

Dipeptidyl Peptidase 4 Inhibitor (6)

  • Tradjenta Linagliptin · Boehringer Ingelheim · 2011
  • Zituvimet Xr Metformin Hydrochloride, Sitagliptin · Zydus Lifesciences · 2024
  • Zituvimet Metformin Hydrochloride, Sitagliptin · Zydus Lifesciences · 2023
  • Zituvio Sitagliptin · Zydus Lifesciences · 2023
  • Jentadueto Xr Linagliptin, Metformin Hydrochloride · Boehringer Ingelheim · 2016
  • Jentadueto Linagliptin, Metformin Hydrochloride · Boehringer Ingelheim · 2012

GLP-1 Receptor Agonist (2)

  • Trulicity Dulaglutide · Eli Lilly and CO · 2014
  • Victoza Liraglutide · Novo Nordisk INC · 2010

Sulfonylurea (2)

  • Duetact Glimepiride, Pioglitazone Hydrochloride · Takeda Pharms USA · 2006
  • Glucotrol Xl Glipizide · Pfizer · 1994

CD3-directed Antibody (1)

  • Tzield Teplizumab-Mzwv · Provention Bio INC · 2022

Nonsteroidal Mineralocorticoid-Receptor Antagonist (1)

  • Kerendia Finerenone · Bayer Hlthcare · 2021

Insulin Analog (1)

  • Basaglar Insulin Glargine · Eli Lilly and CO · 2015

Class not listed in FDA's data (20)

  • Onswik Insulin Efsitora Alfa-Gobe · Eli Lilly and CO · 2026
  • Steglatro Ertugliflozin · Msd Sub Merck · 2017
  • Ozempic Semaglutide · Novo · 2017
  • Farxiga Dapagliflozin · Astrazeneca Ab · 2014
  • Invokana Canagliflozin · Janssen Pharms · 2013
  • Nesina Alogliptin Benzoate · Takeda Pharms USA · 2013
  • Januvia Sitagliptin Phosphate · Msd · 2006
  • Welchol Colesevelam Hydrochloride · Cosette · 2000
  • Actos Pioglitazone Hydrochloride · Takeda Pharms USA · 1999
  • Steglujan Ertugliflozin, Sitagliptin Phosphate · Msd Sub Merck · 2017
  • Segluromet Ertugliflozin, Metformin Hydrochloride · Msd Sub Merck · 2017
  • Invokamet Xr Canagliflozin, Metformin Hydrochloride · Janssen Pharms · 2016
  • Xigduo Xr Dapagliflozin, Metformin Hydrochloride · Astrazeneca Ab · 2014
  • Invokamet Canagliflozin, Metformin Hydrochloride · Janssen Pharms · 2014
  • Kazano Alogliptin Benzoate, Metformin Hydrochloride · Takeda Pharms USA · 2013
  • Oseni Alogliptin Benzoate, Pioglitazone Hydrochloride · Takeda Pharms USA · 2013
  • Janumet Xr Metformin Hydrochloride, Sitagliptin Phosphate · Msd Sub Merck · 2012
  • Cycloset Bromocriptine Mesylate · Veroscience · 2009
  • Janumet Metformin Hydrochloride, Sitagliptin Phosphate · Msd Sub Merck · 2007
  • Actoplus Met Metformin Hydrochloride, Pioglitazone Hydrochloride · Takeda Pharms USA · 2005

Drugs in development for type 1 diabetes

Investigational drugs FDA has not approved, in active or recent industry-sponsored Phase 2 and 3 trials for this condition. Phase 3 first.

Search the pipeline
  • FrexalimabSAR441344Phase 39 trials

    Sanofi · Multiple Sclerosis, Focal Segmental Glomerulosclerosis, Glomerulonephritis Minimal Lesion

  • rilparencelRenal Autologous Cell Therapy, REACTPhase 32 trials

    Prokidney · Type 2 Diabetes Mellitus, Chronic Kidney Diseases, Type 1 Diabetes Mellitus

  • THDB0206Phase 32 trials

    Tonghua Dongbao Pharmaceutical Co.,Ltd · Type 2 Diabetes, Type 1 Diabetes

  • TTP399CadisegliatinPhase 32 trials

    vTv Therapeutics · Type 1 Diabetes (T1D), Diabetes Mellitus, Type 1

  • ZimislecelFormerly known as STx-02, VX-880Phase 32 trials

    Vertex Pharmaceuticals · Type 1 Diabetes, Kidney Transplant, Diabetes Mellitus, Type 1

  • brivekimigSAR442970Phase 25 trials

    Sanofi · Focal Segmental Glomerulosclerosis, Glomerulonephritis Minimal Lesion, Type 1 Diabetes Mellitus

  • BMF-219Phase 22 trials

    Biomea Fusion Inc. · Type 2 Diabetes Mellitus, Type 1 Diabetes Mellitus

  • AcmopatideCT-868, RO7795074Phase 21 trial

    Carmot Therapeutics, Inc. · Overweight, Obese, Type 1 Diabetes Mellitus

  • CNP-103Phase 21 trial

    COUR Pharmaceutical Development Company, Inc. · Type 1 Diabetes Mellitus, T1D, T1DM

  • SAB-142Phase 21 trial

    SAb Biotherapeutics, Inc. · Type 1 Diabetes

  • VX-264Phase 21 trial

    Vertex Pharmaceuticals · Type 1 Diabetes

  • ZT-01Phase 21 trial

    Zucara Therapeutics Inc. · Type 1 Diabetes Mellitus With Hypoglycemia

1 discontinued brand-name drugs whose label still names it

More on type 1 diabetes: recruiting trials · published research

Related in cardiovascular and metabolic: Type 2 diabetes · Obesity and weight management · High blood pressure (hypertension) · Heart failure · High cholesterol · High triglycerides · Atrial fibrillation · Blood clots (DVT and pulmonary embolism) · Stroke prevention · Coronary artery disease and heart attack

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.